Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LIN9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | U2SURP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ZFPL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | MTF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CLSPN | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | MND1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | MCMBP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | FBXO45 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SGTA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |